Advanced Cancer Research in the Midwest United States

 

START Midwest is part of START's global network of Phase I Clinical Research sites. This program offers cancer patients in the Midwest of the United States access to experimental treatments and therapies. START Midwest is able to offer hope to patients facing the toughest cancer battles, while also helping to advance cancer research.

START Research by

The Numbers

 

Square feet of world-class research facilities

Oncology Drugs Brought To Market

Locations across the United States and Europe

Why Participate in a Clinical Trial?

With your participation in a clinical trial, we can develop new cancer treatments that will change how the world fights cancer

 

START Research Capabilities

Phase I Clinical Trials

Clinical Research

This is where we test cancer drugs in human beings for the first time. With 13,000 square feet of testing facilities, START is a global leader in phase I cancer research

START performs clinical research to find new candidates for potential anti-cancer compounds. 27 drugs brought to market is only the beginning

Your START Research Team

The Doctors on the START Research Team are dedicated to developing novel anti-cancer agents. With their expertise and dedication to this science, patients around the world will have new and more effective opportunities to treat their cancers.

 

START Research Blog

 
Contact Us
arrow&v